Effect of oxygen supply on the size of implantable islet-containing encapsulation devices

Panminerva Medica

Volumn 58, Issue 1, 2016, Pages 72-77

  Papas, Klearchos K ^a   Avgoustiniatos, Efstathios S ^b   Suszynski, Thomas M ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Diabetes mellitus, type 1; Equipment and supplies; Oxygen

Indexed keywords

OXYGEN;

ADVERSE EFFECTS; ANIMAL; CELL HYPOXIA; CELL SURVIVAL; DEVICES; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; GRAFT SURVIVAL; HUMAN; METABOLISM; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; PROCEDURES; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL HYPOXIA; CELL SURVIVAL; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; GRAFT SURVIVAL; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; OXYGEN; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84992561331     PISSN: 00310808     EISSN: 18271898     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Barton FB, rickels mr, alejandro r, Hering BJ, Wease S, naziruddin B, et al. improvement in outcomes of clinical islet transplantation: 1999-2010. diabetes care 2012;35:1436-45
2. Bellin md, Barton FB, Heitman a, Harmon Jv, Kandaswamy r, Balamurugan an, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. am J Transplant 2012;12:1576-83
3. Jacobs-Tulleneers-Thevissen d, chintinne m, Ling Z, Gillard P, Schoonjans L, delvaux G, et al. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. diabetologia 2013;56:1605-14
4. Ludwig B, reichel a, Steffen a, Zimerman B, Schally av, Block nL, et al. Transplantation of human islets without immunosuppression. Proc natl acad Sci USa 2013;110:19054-8
5. Hals iK, rokstad am, Strand BL, Oberholzer J, Grill v. alginate microencapsulation of human islets does not increase susceptibility to acute hypoxia. J diabetes res 2013;2013:374925
6. Bruin Je, rezania a, Xu J, narayan K, Fox JK, O'neil JJ, et al. maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice. diabetologia 2013;56:1987-98
7. Kirk K, Hao e, Lahmy r, itkin-ansari P. Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape. Stem cell res 2014;12:807-14
8. motté e, Szepessy e, Suenens K, Stangé G, Bomans m, Jacobs-Tulleneers- Thevissen d, et al. composition and function of macroencapsulated human embryonic stem cell-derived implants: Comparison with clinical human islet cell grafts. am J Physiol endocrinol metab 2014;307: E838-846
9. Pagliuca FW, millman Jr, Gürtler m, Segel m, van dervort a, ryu JH, et al. Generation of Functional Human Pancreatic β Cells In Vitro. cell 2014;159:428-39
10. rezania a, Bruin Je, arora P, rubin a, Batushansky i, asadi a, et al. reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. nat Biotechnol 2014;32:1121-33
11. rezania a, Bruin Je, ridel mJ, mojibian m, asadi a, Xu J, et al. maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. diabetes 2012;61:2016-29
12. Sasikala m, rao Gv, vijayalakshmi v, Pradeep r, Pothani S, Kumar PP, et al. Long-term functions of encapsulated islets grafted in nonhuman primates without immunosuppression. Transplantation 2013;96:624-32
13. Tarantal aF, Lee cc, itkin-ansari P. real-time bioluminescence imaging of macroencapsulated ibroblasts reveals allograft protection in rhesus monkeys (macaca mulatta). Transplantation 2009;88:38-41
14. Colton CK. Implantable biohybrid artiicial organs. Cell Transplant 1995;4:415-36
15. Weir Gc. islet encapsulation: Advances and obstacles. diabetologia 2013;56:1458-61
16. Billing P, Ferguson d, Loudovaris T, Johnson r, ninova d, munn Sr. islets and insulinoma cells within an immunoisolation device demonstrate normal glucose responsiveness in mice. acta diabetologica 1997;34:159
17. Geller rL, Loudovaris T, neuenfeldt S, Johnson rc, Brauker JH. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. ann n Y acad Sci 1997;831:438-51
18. Loudovaris T, mandel Te, charlton B. cd4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of cd8+ T cells and B cells. Transplantation 1996;61:1678-84
19. Johnson rc, Brauker J, Loudovaris T, martinson L, Sternberg Sm. encapsulated cellular transplants: Functional and immunological parameters. J cell Biochem 1995;59 (21B Suppl 6):3
20. Brauker J, carr-Brendel SL, martinson S, Young S, Jacobs r, Geller d, et al. immunoisolation in somatic cell gene therapy. J cell Biochem 1995;59 (21B Suppl 15):6
21. Zhu XH, Zhang N, Zhang Y, Uǧurbil K, Chen W. New insights into central roles of cerebral oxygen metabolism in the resting and stimulus- evoked brain. J cereb Blood Flow metab 2009;29:10-8
22. Zhang N, Zhu XH, Lei H, Ugurbil K, Chen W. Simpliied methods for calculating cerebral metabolic rate of oxygen based on 17O magnetic resonance spectroscopic imaging measurement during a short 17O2 inhalation. J cereb Blood Flow metab 2004;24:840-8
23. Pedraza e, coronel mm, Fraker ca, ricordi c, Stabler cL. Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proc natl acad Sci USa 2012;109:4245-50
24. Ludwig B, rotem a, Schmid J, Weir Gc, colton cK, Brendel md, et al. Improvement of islet function in a bioartiicial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc natl acad Sci USa 2012;109:5022-7
25. ainscow eK, Zhao c, rutter Ga. acute overexpression of lactate dehydrogenase-a perturbs beta-cell mitochondrial metabolism and insulin secretion. diabetes 2000;49:1149-55
26. Zhao c, rutter Ga. Overexpression of lactate dehydrogenase a attenuates glucose-induced insulin secretion in stable min-6 beta-cell lines. FeBS Lett 1998;430:213-6
27. ishihara H, Wang H, drewes Lr, Wollheim cB. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. J clin invest 1999;104:1621-9
28. alcazar O, Tiedge m, Lenzen S. importance of lactate dehydrogenase for the regulation of glycolytic lux and insulin secretion in insulinproducing cells. Biochem J 2000;352 Pt 2:373-80
29. Papas KK, colton cK, Gounarides JS, roos eS, Jarema ma, Shapiro mJ, et al. nmr spectroscopy in beta cell engineering and islet transplantation. ann n Y acad Sci 2001;944:96-119
30. cantley J, Grey ST, maxwell PH, Withers dJ. The hypoxia response pathway and β-cell function. Diabetes Obes Metab 2010;12 (1 Suppl 2):159-67
31. avgoustiniatos eS, colton cK. effect of external oxygen mass transfer resistances on viability of immunoisolated tissue. ann n Y acad Sci 1997;831:145-67
32. Wu H, avgoustiniatos eS, Swette L, Bonner-weir S, Weir Gc, colton cK. in situ electrochemical oxygen generation with an immunoisolation device. ann n Y acad Sci 1999;875:105-25
33. avgoustiniatos eS, colton cK. design considerations in immunoisolation. in: Lanza r, Langer r, chick W, editors, Principles of Tissue engineering. First edition. austin, TX, USa: R.G. Landes; 1997. p. 333-46
34. avgoustiniatos eS, Wu H, colton cK. engineering challenges in immunoisolation device development. in: Lanza rP, Langer r, vicanti J, editors. Principles of Tissue engineering. Second edition. San diego, USa: Academic Press; 2000. p. 331-50
35. dionne Ke, colton cK, Yarmush mL. a microperifusion system with environmental control for studying insulin secretion by pancreatic tissue. Biotechnol Prog 1991;7:359-68
36. dionne Ke, colton cK, Yarmush mL. effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. diabetes 1993;42:12-21
37. Papas KK, Long rc, constantinidis i, Sambanis a. effects of oxygen on metabolic and secretory activities of beta Tc3 cells. Biochim Biophys acta 1996;1291:163-6
38. atchison n, Swindlehurst G, Papas KK, Tsapatsis m, Kokkoli e. Maintenance of ischemic β cell viability through delivery of lipids and aTP by targeted liposomes. Biomater Sci 2014;2:548-59
39. cantley J, Walters Sn, Jung mH, Weinberg a, cowley mJ, Whitworth TP, et al. a preexistent hypoxic gene signature predicts impaired islet graft function and glucose homeostasis. cell Transplant 2013;22:2147-59
40. campbell Pd, Weinberg a, chee J, mariana L, ayala r, Hawthorne WJ, et al. expression of pro- and antiapoptotic molecules of the Bcl-2 family in human islets postisolation. cell Transplant 2012;21:49-60
41. Smith K, Steyn Lv, Weber c, min c, Purvis WG, Stanton JB, et al. direct comparison of adult, juvenile, and neonatal porcine islets in vitro reveals age dependent differences in viability and function. Xenotransplantation 2015;22:64
42. Sörenby aK, Kumagai-Braesch m, Sharma a, Hultenby Kr, Wernerson am, Tibell aB. Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: Studies in a rodent model. Transplantation 2008;86:364-366
43. Tilakaratne HK, Yang B, Hunter SK, andracki me, rodgers vG. can myoglobin expression in pancreatic beta cells improve insulin secretion under hypoxia? an exploratory study with transgenic porcine islets. artif Organs 2007;31:521-31
44. Hyder a, Laue c, Schrezenmeir J. variable responses of islet cells of different ages and species to hypoxia. Transplant Proc 1998;30:578- 80
45. Suszynski Tm, avgoustiniatos eS, Papas KK. intraportal islet Oxygenation. J diabetes Sci Technol 2014;8:575-80
46. Suszynski Tm, Wilhelm JJ, radosevich dm, Balamurugan an, Sutherland de, Beilman GJ, et al. islet size index as a predictor of outcomes in clinical islet autotransplantation. Transplantation 2014;97:1286-91
47. rafael e, Gazelius B, Wu GS, Tibell a. Longitudinal studies on the microcirculation around the Theracyte immunoisolation device, using the laser doppler technique. cell Transplant 2000;9:107-13
48. Suzuki K, Bonner-Weir S, Hollister-Lock J, colton cK, Weir Gc. number and volume of islets transplanted in immunobarrier devices. cell Transplant 1998;7:47-52
49. Tatarkiewicz K, Hollister-Lock J, Quickel rr, colton cK, Bonnerweir S, Weir Gc. reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. Transplantation 1999;67:665-71
50. Suzuki K, Bonner-Weir S, Trivedi n, Yoon KH, Hollister-Lock J, colton cK, et al. Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice. Transplantation 1998;66:21-8
51. Yanay O, Barry Sc, Flint LY, Brzezinski m, Barton rW, Osborne Wr. Long-term erythropoietin gene expression from transduced cells in bioisolator devices. Hum Gene Ther 2003;14:1587-93
52. Bartholomew a, Patil S, mackay a, nelson m, Buyaner d, Hardy W, et al. Baboon mesenchymal stem cells can be genetically modiied to secrete human erythropoietin in vivo. Hum Gene Ther 2001;12:1527- 41
53. Sweet ir, Yanay O, Waldron L, Gilbert m, Fuller Jm, Tupling T, et al. Treatment of diabetic rats with encapsulated islets. J cell mol med 2008;12:2644-50
54. Hussey aJ, Winardi m, Han XL, Thomas GP, Penington aJ, morrison Wa, et al. Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue eng Part a 2009;15:3823-33
55. Hussey aJ, Winardi m, Wilson J, Forster n, morrison Wa, Penington aJ, et al. Pancreatic islet transplantation using vascularised chambers containing nerve growth factor ameliorates hyperglycaemia in diabetic mice. cells Tissues Organs 2010;191:382-93
56. Pedraza e, coronel mm, Fraker ca, ricordi c, Stabler cL. Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proc natl acad Sci USa 2012;09:4245-50
57. Weegman BP, Steyn Lv, einstein Sa, Garwood m, Papas KK. delivery of supplemental oxygen improves oxygenation of tissueengineered grafts in vitro and in vivo as measured with luorine-19 magnetic resonance spectroscopy. Tissue engineering Part a 2015;21:44
58. Steyn Lv, Smith K, Purvis WB, min c, davis ma, Stanton JB, etal. in situ oxygen delivery to islets within an implantable immunoisolating device in vivo engaged their viability and function. Tissue engineering Part a 2015;21:190
59. Steyn Lv, Smith K, Purvis WB, min c, davis ma, mueller Kr, et al. High islet density within a tissue engineered device has a negative impact on viability and function in vivo. Tissue engineering Part a 2015;21:128-9
60. einstein Sa, Weegman BP, Kitzmann JP, Kirkeide Lr, Papas KK, Garwood m. non-invasive assessment of tissue-engineered graft viability with oxygen-17 magnetic resonance spectroscopy. Xenotransplantation 2015;22:94-5
61. irvin a, Kos c, mariana L, Papas KK, Kay T, Loudovaris T. Oxygenation of cell encapsulating devices allows for greater survival of cells in vitro. Xenotransplantation 2015;22:103-4
62. Steyn Lv, davis ma, min c, Smith K, Purvis WG, Stanton JB, et al. in situ oxygen delivery to islets within an implantable immunoisolating device in vivo enhances viability and function. Xenotransplantation 2015;22:197-8
63. Steyn Lv, Smith K, min c, Purvis WG, Stanton JB, davis ma, et al. increasing islet density within an immunoisolation devicehas a detrimental impact on viability in vivo. Xenotransplantation 2015;22:200
64. Weegman B, einstein Sa, Steyn Lv, Suszynski Tm, Firpo mT, Graham mL, et al. continuous oxygen delivery improves oxygenation of tissue-engineered islet grafts in vivo as measured with luorine-10 magnetic resonance spectroscopy. Xenotransplantation 2015;22:128- 9
65. Ludwig B, Zimerman B, Steffen a, Yavriants K, azarov d, reichel a, et al. a novel device for islet transplantation providing immune protection and oxygen supply. Horm metab res 2010;42:918-22
66. Ludwig B, rotem a, Schmid J, Weir Gc, colton cc, Brendel md, et al. Improvement of islet function in a bioartiicial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc natl acad Sci USa 2012;109:5022-7
67. neufeld T, Ludwig B, Barkai U, Weir Gc, colton cK, evron Y, et al. The eficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs. PLoS One 2013;8:e70150
68. Barkai U, Weir Gc, colton cc, Ludwig B, Bornstein Sr, Brendel md, et al. enhanced oxygen supply improves islet viability in a new bioartiicial pancreas. Cell Transplant 2013;22:1463-76